Long-Term Treatment Outcome of Entecavir (ETV) Monotherapy in Treatment-Naive Hepatitis B e Antigen-positive Chronic Hepatitis B (CHB) Patients in a Real-Life Setting

被引:0
|
作者
Ha, Nghi [1 ]
Ha, Nghiem [3 ]
Garcia, Ruel [2 ]
Trinh, Huy [2 ]
Do, Ailinh [1 ]
Nguyen, Huy [2 ]
Nguyen, Khanh [2 ]
Levitt, Brian [2 ]
Nguyen, Mindie [3 ]
机构
[1] Pacific Hlth Fdn, San Jose, CA USA
[2] San Jose Gastroenterol, San Jose, CA USA
[3] Stanford Univ, Med Ctr, GI & Hepatol, Palo Alto, CA 94304 USA
来源
关键词
D O I
10.14309/00000434-200910003-00348
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
348
引用
收藏
页码:S131 / S132
页数:2
相关论文
共 50 条
  • [21] OUTCOME OF 4-YEAR TREATMENT OF ENTECAVIR FOR TREATMENT-NAIVE CHRONIC HEPATITIS B
    Seto, W-K.
    Lai, C-L.
    Fung, J.
    Yuen, J. C-H.
    Wong, D. K-H.
    Yuen, M-F.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S301 - S301
  • [22] LOW INCIDENCE OF HEPATITIS B E ANTIGEN (HBEAG) SEROCONVERSION WITH ORAL MONOTHERAPY IN CHRONIC HEPATITIS B (CHB) TREATMENT-NAiVE PATIENTS AT YEAR 1 IN CLINICAL PRACTICE
    Lin, Brian
    Ha, Nghiem B.
    Liu, Anne
    Trinh, Huy N.
    Nguyen, Huy A.
    Nguyen, Khanh
    Garcia, Ruel T.
    Keeffe, Emmet B.
    Garcia, Gabriel
    Ahmed, Aijaz
    Nguyen, Minde H.
    HEPATOLOGY, 2011, 54 : 1045A - 1046A
  • [23] Entecavir therapy for treatment-naive chronic hepatitis B patients in Taiwan
    Dai, C.
    Yeh, M.
    Huang, C.
    Huang, C.
    Hou, N.
    Hsieh, M.
    Huang, J.
    Lin, Z.
    Chen, S.
    Tsai, J.
    Yu, M.
    Chuang, W.
    JOURNAL OF VIRAL HEPATITIS, 2012, 19 : 25 - 26
  • [24] NONCOMPLIANCE, ANTIVIRAL RESISTANCE, AND VIROLOGIC RESPONSE (VR) IN TREATMENT-NAiVE HBEAG-NEGATIVE PATIENTS WITH CHRONIC HEPATITIS B (CHB) ON LONG-TERM THERAPY WITH ENTECAVIR 0.5 MG (ETV) OR ADEFOVIR 10 MG (ADV) IN A REAL-LIFE CLINICAL SETTING
    Ha, Nghiem B.
    Ha, Nghi B.
    Garcia, Ruel T.
    Trinh, Huy N.
    Nguyen, Khanh K.
    Nguyen, Huy A.
    Levitt, Brian S.
    Vu, Andrew A.
    Nguyen, Mindie H.
    HEPATOLOGY, 2009, 50 (04) : 513A - 513A
  • [25] Rescue monotherapy in lamivudine-resistant hepatitis B e antigen-positive chronic hepatitis B: adefovir versus entecavir
    Lee, Jung Min
    Kim, Hyung Joon
    Park, Jun Yong
    Lee, Chun Kyon
    Kim, Do Young
    Kim, Ja Kyung
    Lee, Hyun Woong
    Paik, Yong Han
    Lee, Kwan Sik
    Han, Kwang-Hyub
    Chon, Chae Yoon
    Hong, Sun Pyo
    Nguyen, Tin
    Ahn, Sang Hoon
    ANTIVIRAL THERAPY, 2009, 14 (05) : 705 - 712
  • [26] Entecavir for the long-term treatment of chronic hepatitis B
    Gonzalez, Stevan A.
    Keeffe, Emmet B.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2009, 7 (09) : 1053 - 1062
  • [27] Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive nucleoside-naive patients treated with entecavir
    Gish, Robert G.
    Chang, Ting-Tsung
    Lai, Ching-Lung
    de Man, Robert A.
    Gadano, Adrian
    Llamoso, Cyril
    Tang, Hong
    ANTIVIRAL THERAPY, 2013, 18 (05) : 691 - 698
  • [28] PREDICTORS OF SEVERE HEPATIC FIBROSIS IN TREATMENT-NAIVE GENOTYPE B OR C INFECTED E ANTIGEN-POSITIVE AND -NEGATIVE CHRONIC HEPATITIS B PATIENTS
    Su, W. -P.
    Peng, C. -Y.
    Lai, H. -C.
    Lin, C. -H.
    Chuang, P. -H.
    Chen, S. -H.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S290 - S291
  • [29] Efficacy of Real-world Entecavir Therapy in Treatment-naive Chronic Hepatitis B Patients
    Xie, Yan-Di
    Ma, Hui
    Feng, Ba
    Wei, Lai
    CHINESE MEDICAL JOURNAL, 2017, 130 (18) : 2190 - 2197
  • [30] Hepatitis B surface antigen quantification at hepatitis B e antigen seroconversion predicts virological relapse after the cessation of entecavir treatment in hepatitis B e antigen-positive patients
    Qiu, Yuan-wang
    Huang, Li-hua
    Yang, Wen-long
    Wang, Zhen
    Zhang, Bo
    Li, Yi-guang
    Su, Ting-ting
    Zhou, Hong-yan
    Xu, Wei
    Wang, Xue-dong
    Dai, Ya-ping
    Gan, Jian-he
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 43 : 43 - 48